Abstract 081: Clinical Presentation and Treatment of 26 Spinal Epidural Arteriovenous Fistulas: A Single Center Experience

Introduction Spinal epidural arteriovenous fistulas (SEAVFs) are rarely diagnosed vascular malformations that can cause spinal cord compression and congestive myelopathy. Methods This is a single center, retrospective case series of patients with SEAVF who underwent observation or treatment at UCLA...

Full description

Saved in:
Bibliographic Details
Main Authors: Charles Beaman, Amir Molaie, Yasmin Ghochani, Keiko Fukuda, Catherine Peterson, Naoki Kaneko, May Nour, Viktor Szeder, Geoffrey Colby, Satoshi Tateshima, Reza Jahan, Gary Duckwiler
Format: Article
Language:English
Published: Wiley 2023-11-01
Series:Stroke: Vascular and Interventional Neurology
Online Access:https://www.ahajournals.org/doi/10.1161/SVIN.03.suppl_2.081
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850268351043993600
author Charles Beaman
Amir Molaie
Yasmin Ghochani
Keiko Fukuda
Catherine Peterson
Naoki Kaneko
May Nour
Viktor Szeder
Geoffrey Colby
Satoshi Tateshima
Reza Jahan
Gary Duckwiler
author_facet Charles Beaman
Amir Molaie
Yasmin Ghochani
Keiko Fukuda
Catherine Peterson
Naoki Kaneko
May Nour
Viktor Szeder
Geoffrey Colby
Satoshi Tateshima
Reza Jahan
Gary Duckwiler
author_sort Charles Beaman
collection DOAJ
description Introduction Spinal epidural arteriovenous fistulas (SEAVFs) are rarely diagnosed vascular malformations that can cause spinal cord compression and congestive myelopathy. Methods This is a single center, retrospective case series of patients with SEAVF who underwent observation or treatment at UCLA medical center from 1993 to 2023. Results A total of 26 patients were found to have a SEAVF at UCLA from 1993 to 2023. The median age at treatment was 59 years (range 4 months to 91 years). 16 of 26 patients (55.2%) were male. 12 were located in the cervical spine, 2 in the thoracic spine, 11 in the lumbar spine, and 1 in the sacral spine. Sacral, lumbar, and thoracic SEAVFs demonstrated a strong male predominance (12 of 14, 85.7%), while cervical SEAVFs were more common in women (8 of 12, 66.7%). The median duration of symptoms prior to treatment was 6.5 months (range 1 day to 8 years). Possible triggers included prior spinal surgery (n=3), turning neck (n=1), trauma to the neck (n=1), lifting a heavy box (n=1), prolonged period of bending over (n=1). The remaining patients did not have any particular trigger. All patients with lumbar and thoracic SEAVFs (except the 3‐month‐old) demonstrated flow voids and cord edema. Patients with cervical SEAVF did not demonstrate cord edema and only 5 of 12 explicitly mentioned flow voids. 22 patients were treated strictly endovascularly, 1 patient endovascularly and then surgically, 1 patient surgically, and 2 patients refused treatment. No patients treated endovascularly experienced complications. 19 of 23 patients (82.6%) treated endovascularly received complete cure after the first treatment. 1 patient had a successful subsequent embolization 2 days later. Of the 3 other incomplete treatments, one patient received subsequent successful surgery, one patient was a 3‐month‐old patient with Parkes‐Weber syndrome who subsequently died of other medical issues, and one was lost to follow‐up. One patient underwent surgical treatment alone due to the feeding arteries being too small to catheterize and unfortunately experienced a failed surgery on the first attempt and developed a surgical site infection after the second successful attempt at treatment. Onyx was used in 10 cases (9 of 10 successful). 2 cases treated with NBCA were unsuccessful. Cervical and Sacral SEAVFs were treated successfully (mostly prior to 2006) with coils and/or detachable balloons. Conclusion SEAVF is a rare disease that can be treated effectively and safely with endovascular embolization in most cases. Pre‐operative MRI demonstrated abnormalities in all cases. We found a strong male predominance in our cohort.
format Article
id doaj-art-c9ab4247fa974528a6d1176659cbdeef
institution OA Journals
issn 2694-5746
language English
publishDate 2023-11-01
publisher Wiley
record_format Article
series Stroke: Vascular and Interventional Neurology
spelling doaj-art-c9ab4247fa974528a6d1176659cbdeef2025-08-20T01:53:30ZengWileyStroke: Vascular and Interventional Neurology2694-57462023-11-013S210.1161/SVIN.03.suppl_2.081Abstract 081: Clinical Presentation and Treatment of 26 Spinal Epidural Arteriovenous Fistulas: A Single Center ExperienceCharles Beaman0Amir Molaie1Yasmin Ghochani2Keiko Fukuda3Catherine Peterson4Naoki Kaneko5May Nour6Viktor Szeder7Geoffrey Colby8Satoshi Tateshima9Reza Jahan10Gary Duckwiler11UCLA Medical Center California United StatesUCLA Medical Center California United StatesUCLA Medical Center California United StatesUCLA Medical Center California United StatesUCLA Medical Center California United StatesUCLA Medical Center California United StatesUCLA Medical Center California United StatesUCLA Medical Center California United StatesUCLA Medical Center California United StatesUCLA Medical Center California United StatesUCLA Medical Center California United StatesUCLA Medical Center California United StatesIntroduction Spinal epidural arteriovenous fistulas (SEAVFs) are rarely diagnosed vascular malformations that can cause spinal cord compression and congestive myelopathy. Methods This is a single center, retrospective case series of patients with SEAVF who underwent observation or treatment at UCLA medical center from 1993 to 2023. Results A total of 26 patients were found to have a SEAVF at UCLA from 1993 to 2023. The median age at treatment was 59 years (range 4 months to 91 years). 16 of 26 patients (55.2%) were male. 12 were located in the cervical spine, 2 in the thoracic spine, 11 in the lumbar spine, and 1 in the sacral spine. Sacral, lumbar, and thoracic SEAVFs demonstrated a strong male predominance (12 of 14, 85.7%), while cervical SEAVFs were more common in women (8 of 12, 66.7%). The median duration of symptoms prior to treatment was 6.5 months (range 1 day to 8 years). Possible triggers included prior spinal surgery (n=3), turning neck (n=1), trauma to the neck (n=1), lifting a heavy box (n=1), prolonged period of bending over (n=1). The remaining patients did not have any particular trigger. All patients with lumbar and thoracic SEAVFs (except the 3‐month‐old) demonstrated flow voids and cord edema. Patients with cervical SEAVF did not demonstrate cord edema and only 5 of 12 explicitly mentioned flow voids. 22 patients were treated strictly endovascularly, 1 patient endovascularly and then surgically, 1 patient surgically, and 2 patients refused treatment. No patients treated endovascularly experienced complications. 19 of 23 patients (82.6%) treated endovascularly received complete cure after the first treatment. 1 patient had a successful subsequent embolization 2 days later. Of the 3 other incomplete treatments, one patient received subsequent successful surgery, one patient was a 3‐month‐old patient with Parkes‐Weber syndrome who subsequently died of other medical issues, and one was lost to follow‐up. One patient underwent surgical treatment alone due to the feeding arteries being too small to catheterize and unfortunately experienced a failed surgery on the first attempt and developed a surgical site infection after the second successful attempt at treatment. Onyx was used in 10 cases (9 of 10 successful). 2 cases treated with NBCA were unsuccessful. Cervical and Sacral SEAVFs were treated successfully (mostly prior to 2006) with coils and/or detachable balloons. Conclusion SEAVF is a rare disease that can be treated effectively and safely with endovascular embolization in most cases. Pre‐operative MRI demonstrated abnormalities in all cases. We found a strong male predominance in our cohort.https://www.ahajournals.org/doi/10.1161/SVIN.03.suppl_2.081
spellingShingle Charles Beaman
Amir Molaie
Yasmin Ghochani
Keiko Fukuda
Catherine Peterson
Naoki Kaneko
May Nour
Viktor Szeder
Geoffrey Colby
Satoshi Tateshima
Reza Jahan
Gary Duckwiler
Abstract 081: Clinical Presentation and Treatment of 26 Spinal Epidural Arteriovenous Fistulas: A Single Center Experience
Stroke: Vascular and Interventional Neurology
title Abstract 081: Clinical Presentation and Treatment of 26 Spinal Epidural Arteriovenous Fistulas: A Single Center Experience
title_full Abstract 081: Clinical Presentation and Treatment of 26 Spinal Epidural Arteriovenous Fistulas: A Single Center Experience
title_fullStr Abstract 081: Clinical Presentation and Treatment of 26 Spinal Epidural Arteriovenous Fistulas: A Single Center Experience
title_full_unstemmed Abstract 081: Clinical Presentation and Treatment of 26 Spinal Epidural Arteriovenous Fistulas: A Single Center Experience
title_short Abstract 081: Clinical Presentation and Treatment of 26 Spinal Epidural Arteriovenous Fistulas: A Single Center Experience
title_sort abstract 081 clinical presentation and treatment of 26 spinal epidural arteriovenous fistulas a single center experience
url https://www.ahajournals.org/doi/10.1161/SVIN.03.suppl_2.081
work_keys_str_mv AT charlesbeaman abstract081clinicalpresentationandtreatmentof26spinalepiduralarteriovenousfistulasasinglecenterexperience
AT amirmolaie abstract081clinicalpresentationandtreatmentof26spinalepiduralarteriovenousfistulasasinglecenterexperience
AT yasminghochani abstract081clinicalpresentationandtreatmentof26spinalepiduralarteriovenousfistulasasinglecenterexperience
AT keikofukuda abstract081clinicalpresentationandtreatmentof26spinalepiduralarteriovenousfistulasasinglecenterexperience
AT catherinepeterson abstract081clinicalpresentationandtreatmentof26spinalepiduralarteriovenousfistulasasinglecenterexperience
AT naokikaneko abstract081clinicalpresentationandtreatmentof26spinalepiduralarteriovenousfistulasasinglecenterexperience
AT maynour abstract081clinicalpresentationandtreatmentof26spinalepiduralarteriovenousfistulasasinglecenterexperience
AT viktorszeder abstract081clinicalpresentationandtreatmentof26spinalepiduralarteriovenousfistulasasinglecenterexperience
AT geoffreycolby abstract081clinicalpresentationandtreatmentof26spinalepiduralarteriovenousfistulasasinglecenterexperience
AT satoshitateshima abstract081clinicalpresentationandtreatmentof26spinalepiduralarteriovenousfistulasasinglecenterexperience
AT rezajahan abstract081clinicalpresentationandtreatmentof26spinalepiduralarteriovenousfistulasasinglecenterexperience
AT garyduckwiler abstract081clinicalpresentationandtreatmentof26spinalepiduralarteriovenousfistulasasinglecenterexperience